Viewing Study NCT04517851


Ignite Creation Date: 2025-12-24 @ 11:56 PM
Ignite Modification Date: 2025-12-25 @ 9:53 PM
Study NCT ID: NCT04517851
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-18
First Post: 2020-08-14
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Elotuzumab for the Treatment of JAK2-Mutated Myelofibrosis
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module